Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Congress Scientific Watch

The Congress Scientific Watch provides ESMO Members with fresh comments and analysis from selected abstracts presented during major international Oncology meetings (in partnership with medwireNews).

Video interviews from AACR 2022

Filter by:

58 results

Clinical Research;  Germ Cell Tumours;  Immunotherapy

Claudin-6 Targeted CAR-T Cell Product Shows Promise in Solid Tumours

From the 2022 AACR Annual Meeting:
People with solid tumours, particularly testicular cancer, could benefit from claudin-6 targeted CAR-T cell therapy alone or in combination with a vaccine designed to boost CAR-T cell persistence

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.